Research & Development

How Have Keytruda and Opdivo Transformed Cancer Treatment?
Research & Development How Have Keytruda and Opdivo Transformed Cancer Treatment?

In the evolving landscape of cancer treatment, the advent of immunotherapies Keytruda and Opdivo has marked a groundbreaking shift. Over the last decade, these drugs, known as PD1 inhibitors, have revolutionized oncology, offering new hope and significantly altering patient outcomes. Their story is

ArsenalBio Secures $325M in Major Boost for Cancer Cell Therapy Development
Research & Development ArsenalBio Secures $325M in Major Boost for Cancer Cell Therapy Development

Arsenal Biosciences, commonly known as ArsenalBio, has achieved a remarkable milestone by securing $325 million in a Series C funding round. This significant financial boost arrives amid a challenging year for biotech investments, particularly in the cell and gene therapy sectors. The raised

Sanofi's MS Drug Tolebrutinib Shows Promise Despite Mixed Results
Research & Development Sanofi's MS Drug Tolebrutinib Shows Promise Despite Mixed Results

Sanofi, a leading pharmaceutical company, recently announced the results of its clinical trials for tolebrutinib, an experimental drug targeting multiple sclerosis (MS). The mixed outcomes have generated a buzz within the medical and investment communities. While the drug did not outperform an

Vaxcyte's Pneumococcal Vaccine Shows Promise, Shakes Up Market
Research & Development Vaxcyte's Pneumococcal Vaccine Shows Promise, Shakes Up Market

In a significant development for the pneumococcal vaccine market, Vaxcyte has announced promising results from its Phase 1/2 trials, unveiling a vaccine that has the potential to challenge established leaders like Pfizer's Prevnar 20. The initial data not only showcases impressive efficacy but has

Billion-Dollar Deals Drive Innovation in Oncology Research and Development
Research & Development Billion-Dollar Deals Drive Innovation in Oncology Research and Development

The landscape of biopharmaceutical research and development (R&D) has seen a remarkable evolution, particularly in the realm of oncology. In recent years, a significant portion of R&D investments has been channeled into cancer research, paving the way for groundbreaking treatments and therapies.

Recursion Confirms Safety of Experimental Drug REC-994, Efficacy Uncertain
Research & Development Recursion Confirms Safety of Experimental Drug REC-994, Efficacy Uncertain

Recursion Pharmaceuticals has reached a significant milestone in its journey to develop a treatment for cerebral cavernous malformation (CCM), a complex neurovascular condition. The company's leading experimental drug, REC-994, recently concluded a Phase 2 clinical trial, and the results are both

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later